gmp compressed air iso8573-1 class 2 pharmaceutical specification source

The Central Role of Compressed Air in the Pharmaceutical Industry

In pharmaceutical manufacturing, compressed air serves as a critical process medium and is extensively used for material transfer, equipment purging, oxygen supply in fermentation, and maintaining the environment in cleanrooms. Because it comes into direct or indirect contact with drug solutions, primary packaging materials, or aseptic processing areas, its quality directly affects the safety and efficacy of the final product. Regulatory agencies worldwide have included compressed air systems within the scope of GMP (Good Manufacturing Practice) oversight, mandating the establishment of a comprehensive quality system that covers everything from air source treatment to end‑use applications.

ISO 8573-1 Class 2 Standard Analysis

Published by the International Organization for Standardization ISO 8573-1 is the mainstream international standard for assessing compressed air quality. The standard employs a tiered framework to independently quantify three core contaminants:Particulate matter,Moisture (Pressure Dew Point)andOily substances. Class 2 It belongs to a higher cleanliness class and typically corresponds to the following technical specifications:

• Solid particles: The maximum allowable particle count is significantly lower than that of lower‑grade standards across commonly used measurement size ranges, relying on high‑precision filters to achieve this.
• Moisture: The pressure dew point typically needs to be maintained between -40°C and -70°C to effectively minimize the risk of condensate formation and microbial growth.
• Oil content: Total oil mist, oil vapor, and condensable hydrocarbon residues are strictly limited to prevent cross-contamination.

This class is commonly used in sensitive processes such as aseptic formulation filling lines, cell culture aeration, lyophilization chamber purging, and the synthesis of high-purity active pharmaceutical ingredients.

Sources and Basis in GMP Regulations

Although the GMP texts of major global pharmaceutical regulatory systems do not uniformly mandate the specific marking of standard numbers, they all list air purification effectiveness as a mandatory technical requirement and generally cite it. ISO 8573-1 serves as a technical validation benchmark. For example, EU GMP Annex 1 on Sterile Medicinal Products explicitly requires compressed air used in sterile environments to meet specific purity standards and recommends referencing ISO 8573-1 Perform performance qualification. The Appendix to China’s Good Manufacturing Practice for Pharmaceuticals and related technical guidelines state that process gases must undergo effective purification and sterilization, with regular testing for particulates, moisture, oil content, and microbial limits. U.S. cGMP and relevant WHO technical reports likewise include compressed air quality as a core component of facility and equipment validation, requiring companies to establish clear acceptance criteria based on product characteristics.

Key Points for Control and Monitoring in Actual Production

To meet Class 2 To meet process requirements at this level, pharmaceutical companies must establish a closed-loop gas supply management system. Key elements include a multi-stage filtration strategy—featuring pre-filtration to remove particulates, refrigerated or adsorption drying, and terminal sterile filtration—along with online particle counters and dew-point sensors for real-time data monitoring, complemented by regular offline calibration and integrity testing. Piping layouts should adhere to gravity‑drainage principles, eliminating dead legs and low points where liquid can accumulate; materials must meet pharmaceutical‑grade standards for corrosion resistance and low leachables. All monitoring records must be incorporated into deviation investigation protocols and annual product quality review analyses to ensure the system consistently meets predefined quality specifications throughout its lifecycle.